The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment.
Oncology
Chicago-based Northwestern Medicine confirmed to Becker's that it filed applications with the state Feb. 15, seeking approval for a proposed $75 million expansion of its cancer center in Warrenville, Ill.
Jonathan Uhr, MD, a medical researcher who expanded knowledge on antibodies and cancer treatments, died of prostate cancer on Feb. 15. He was 96, The Washington Post reported.
The National Institutes of Health has awarded funding to eight medical groups that will become part of its inaugural Cancer Screening Research Network, an effort to advance existing knowledge about emerging cancers, early detection and treatment, it announced Feb. 21.
The University of Cincinnati Cancer Center is the first site in the Midwest to launch a phase 2 clinical trial to test a pancreatic cancer vaccine.
Advertisement
Francisco Esteva, MD, PhD, was appointed chief of hematology and medical oncology at three hospitals.
There may be a new tool in the arsenal of the fight against cancer — more specifically, in the fight against HPV-caused cancers, which do not respond as well to traditional treatment methods like chemotherapy or radiation.
Boston-based Mass General Brigham Cancer is promoting three of its leaders, according to a memo shared with Becker's.
The days between a new cancer diagnosis and the next oncologist appointment are agonizing. This hard truth made one Florida hospital commit to act quicker.
Sam Yoon, MD, chief of the surgical oncology division at New York City-based Columbia University Irving Medical Center, is facing scrutiny after a blogger found concerns with the images and data published in many of his research papers, The New…